Next, the effect of CRISPR/Cas9 GPC4 on the proliferation of SNB-75 and SF-295 glioblastoma cells and HOP-92 non-small cell lung adenocarcinoma cells was investigated. This evidence concerns the gene GPC4 and non-small cell lung adenocarcinoma.